Stitcher
06-19-2008, 09:41 AM
Suven Life starts clinical trials of its molecule
Business Standard India Wed, 18 Jun 2008 1:37 AM PDT
http://www.business-standard.com/common/storypage_c_online.php?leftnm=10&bKeyFlag=IN&autono=40207
Hyderabad-based drug discovery and development company Suven Life Sciences stated that it has started phase-I clinical trials of its molecule SUVN-502, intended for treatment of Alzheimer's disease and other disorders of memory and cognition like attention deficient hyperactivity, Parkinson's and Schizophrenia.
READ article (http://www.business-standard.com/common/storypage_c_online.php?leftnm=10&bKeyFlag=IN&autono=40207)
Business Standard India Wed, 18 Jun 2008 1:37 AM PDT
http://www.business-standard.com/common/storypage_c_online.php?leftnm=10&bKeyFlag=IN&autono=40207
Hyderabad-based drug discovery and development company Suven Life Sciences stated that it has started phase-I clinical trials of its molecule SUVN-502, intended for treatment of Alzheimer's disease and other disorders of memory and cognition like attention deficient hyperactivity, Parkinson's and Schizophrenia.
READ article (http://www.business-standard.com/common/storypage_c_online.php?leftnm=10&bKeyFlag=IN&autono=40207)